Skip to content

The effects of tuina on patients with obstructive sleep apnea/hypopnea syndrome

The effects of tuina on patients with obstructive sleep apnea/hypopnea syndrome: a one-year single-blind randomised trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN98859152
Enrollment
30
Registered
2014-04-04
Start date
2010-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea/Hypopnea Syndrome Nervous System Diseases Sleep apnoea

Interventions

Patients were randomised to receive either tuina treatment or no treatment. The patients received tuina treatment two times per week for 10 weeks. When we used tuina for treatment, the definite cours

Sponsors

Kaohsiung Chang Gung Memorial Hospital (Taiwan)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. OSAHS patients who refused conservative therapies or surgery recruited from the outpatient clinic of the sleep center of Chang Gung Memorial Hospital (CGMH) ? Kaohsiung Medical Center 2. OSAHS confirmed by a full polysomnographic study

Exclusion criteria

Exclusion criteria: 1. High alcohol intake (> 80 g/day) 2. Morbid obesity 3. Significant lung disease 4. Neurological disease 5. Intellectual deficits 6. Skeletal facial framework problems 7. Central apnea 8. Using of any hypnotic drugs or previous oropharyngeal surgery

Design outcomes

Primary

MeasureTime frame
1. Polysomnography (PSG) 2. Neck circumference (NC, cm) 3. Body mass index (BMI, body weight/height2=kg/m2) The subjective and objective outcome measures were checked pretreatment (baseline) and 3 months after treatment.

Secondary

MeasureTime frame
1. Medical outcomes study 36-item Short-Form Health Survey (SF-36) 2. Snoring intensity was evaluated by a ten-point visual analog scale 3. Epworth Sleepiness Scale (ESS) The subjective and objective outcome measures were checked pretreatment (baseline) and 3 months after treatment.

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026